BioSpace News Archive

Genetown

Roivant to Present at Targeted Protein Degradation Conference

Roivant Sciences announced that its CEO Matt Gline will present at Guggenheim’s Targeted Protein Degradation Day on Wednesday, March 16, 2022 at 1:15 p.m. ET.

March 11, 2022
·
3 min read
Business

Cipher Pharmaceuticals Schedules Q4 2021 Earnings Release and Conference Call

Cipher Pharmaceuticals Inc. announced that it will release its financial and operating results for the three and twelve months ended December 31, 2021 after market close on March 17, 2022.

March 11, 2022
·
1 min read
Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period

Helix BioPharma Corp. announces that it has closed a private placement financing for gross proceeds of $1,001,000 from the issuance of 3,850,000 common share at a price of $0.26 per common share.

March 11, 2022
·
11 min read
CORRECTION: Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period

Helix BioPharma Corp. announces that it has closed a private placement financing for gross proceeds of $1,001,000 from the issuance of 3,850,000 common share at a price of $0.26 per common share.

March 11, 2022
·
11 min read
Business

Kiromic BioPharma Provides Business Update and Reports Third Quarter 2021 Financial Results

Kiromic BioPharma, Inc. reported business updates and financial results for its third quarter ending September 30, 2021.

March 11, 2022
·
12 min read
Business

Mary Rhinehart Named Interim President and CEO of Lubrizol

The Lubrizol Corporation announced that Mary Rhinehart will serve as president and CEO on an interim basis, effective immediately.

March 11, 2022
·
1 min read
Pharm Country

AnPac Bio-Medical Sciences Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement

AnPac Bio-Medical Science Co., Ltd. announced that on March 8, 2022, it received a written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC indicating that the Company is not in compliance with the minimum bid price requirement of US$1.00 per share under the Nasdaq Listing Rules.

March 11, 2022
·
6 min read